Wong NS - Search Results

1

Hormone receptor and c-ERBB2 status in distant metastatic and locally recurrent breast cancer. Pathologic correlations and clinical significance.

Idirisinghe PK, Thike AA, Cheok PY, Tse GM, Lui PC, Fook-Chong S, Wong NS, Tan PH. Idirisinghe PK, et al. Among authors: wong ns. Am J Clin Pathol. 2010 Mar;133(3):416-29. doi: 10.1309/AJCPJ57FLLJRXKPV. Am J Clin Pathol. 2010. PMID: 20154280

2

Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers.

Thike AA, Iqbal J, Cheok PY, Chong AP, Tse GM, Tan B, Tan P, Wong NS, Tan PH. Thike AA, et al. Among authors: wong ns. Am J Surg Pathol. 2010 Jul;34(7):956-64. doi: 10.1097/PAS.0b013e3181e02f45. Am J Surg Pathol. 2010. PMID: 20495445

3

Therapeutic targets in triple negative breast cancer - where are we now?

Teng YH, Thike AA, Wong NS, Tan PH. Teng YH, et al. Among authors: wong ns. Recent Pat Anticancer Drug Discov. 2011 May;6(2):196-209. doi: 10.2174/157489211795328521. Recent Pat Anticancer Drug Discov. 2011. PMID: 21247402 Review.

4

Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy.

Teng YH, Tan WJ, Thike AA, Cheok PY, Tse GM, Wong NS, Yip GW, Bay BH, Tan PH. Teng YH, et al. Among authors: wong ns. Breast Cancer Res. 2011 Apr 1;13(2):R35. doi: 10.1186/bcr2857. Breast Cancer Res. 2011. PMID: 21457545 Free PMC article.

5

Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.

Chan M, Ji SM, Liaw CS, Yap YS, Law HY, Yoon CS, Wong CY, Yong WS, Wong NS, Ng R, Ong KW, Madhukumar P, Oey CL, Tan PH, Li HH, Ang P, Ho GH, Lee AS. Chan M, et al. Among authors: wong ns, wong cy. Breast Cancer Res Treat. 2012 Nov;136(1):209-20. doi: 10.1007/s10549-012-2234-y. Epub 2012 Sep 11. Breast Cancer Res Treat. 2012. PMID: 22965832

6

ETV6 disruption does not predict indolent clinical behavior in secretory breast carcinoma.

Wong M, Jara-Lazaro AR, Hui Ng RC, Tiong Lim AS, Cheok PY, Lim TH, Tan PH, Wong NS. Wong M, et al. Among authors: wong ns. Breast J. 2012 Nov-Dec;18(6):604-6. doi: 10.1111/tbj.12041. Epub 2012 Oct 19. Breast J. 2012. PMID: 23078524 No abstract available.

7

Evaluation of three polygenic risk score models for the prediction of breast cancer risk in Singapore Chinese.

Chan CHT, Munusamy P, Loke SY, Koh GL, Yang AZY, Law HY, Yoon CS, Wong CY, Yong WS, Wong NS, Ng RCH, Ong KW, Madhukumar P, Oey CL, Ho GH, Tan PH, Tan MH, Ang P, Yap YS, Lee ASG. Chan CHT, et al. Among authors: wong ns, wong cy. Oncotarget. 2018 Jan 31;9(16):12796-12804. doi: 10.18632/oncotarget.24374. eCollection 2018 Feb 27. Oncotarget. 2018. PMID: 29560110 Free PMC article.

8

Phase I/II study of gemcitabine with pegylated liposomal doxorubicin as first-line therapy in Asian women with metastatic breast cancer.

Wong ZW, Ang PC, Chowbay B, Wong NS, See HT, Khoo KS. Wong ZW, et al. Among authors: wong ns. Breast. 2008 Oct;17(5):517-22. doi: 10.1016/j.breast.2008.03.009. Epub 2008 May 23. Breast. 2008. PMID: 18502128 Free article. Clinical Trial.

9

PXR pharmacogenetics: association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patients.

Sandanaraj E, Lal S, Selvarajan V, Ooi LL, Wong ZW, Wong NS, Ang PC, Lee EJ, Chowbay B. Sandanaraj E, et al. Among authors: wong zw, wong ns. Clin Cancer Res. 2008 Nov 1;14(21):7116-26. doi: 10.1158/1078-0432.CCR-08-0411. Clin Cancer Res. 2008. PMID: 18981011 Free article.

10

Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growth factor receptor levels as markers of response.

Wong NS, Buckman RA, Clemons M, Verma S, Dent S, Trudeau ME, Roche K, Ebos J, Kerbel R, Deboer GE, Sutherland DJ, Emmenegger U, Slingerland J, Gardner S, Pritchard KI. Wong NS, et al. J Clin Oncol. 2010 Feb 10;28(5):723-30. doi: 10.1200/JCO.2009.24.0143. Epub 2009 Dec 21. J Clin Oncol. 2010. PMID: 20026801 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

247 results

Search Page

Filters